In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Arrogate Last to First in Dubai World Cup
- Hence Springs Upset in Sunland Derby
- Dortmund Back to Dirt in Next Start
- Undefeated Ghalia Takes Sunland Park Oaks
- Girvin Heads Louisiana Derby Field
- Fast and Accurate Scores Spiral Upset
- Fear the Cowboy Takes Skip Away in Late Drive
- Thunder Snow Gets Up in UAE Derby
- Mind Your Biscuits Rises to Occasion in Golden Shaheen
- Farrell Poised for Next Test in Fair Grounds Oaks